Peer-Review Report of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14308)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 14, 2021 (publication date) through Mar 17, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Goulart MR, Stasinos K, Fincham REA, Delvecchio FR, Kocher HM. T cells in pancreatic cancer stroma. World J Gastroenterol 2021; 27(46): 7956-7968 [PMID: 35046623 DOI: 10.3748/wjg.v27.i46.7956] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Goulart MR, Stasinos K, Fincham REA, Delvecchio FR, Kocher HM. T cells in pancreatic cancer stroma. World J Gastroenterol 2021; 27(46): 7956-7968 [PMID: 35046623 DOI: 10.3748/wjg.v27.i46.7956] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i46/7956.htm |
| Number | Citing Articles |
| 1 |
Pancreatic Cancer: Basic Mechanisms and Therapies. Advances in Cancer Research 2023; 159: 113 doi: 10.1016/bs.acr.2023.02.003
|
| 2 |
Anja Geisler, Babette Dieringer, Leslie Elsner, Robert Klopfleisch, Jens Kurreck, Henry Fechner. Oncolytic Coxsackievirus B3 Strain PD-H Is Effective Against a Broad Spectrum of Pancreatic Cancer Cell Lines and Induces a Growth Delay in Pancreatic KPC Cell Tumors In Vivo. International Journal of Molecular Sciences 2024; 25(20): 11224 doi: 10.3390/ijms252011224
|
| 3 |
Ziniu Tang, Chen Wang, Zhenyu Ma, Peng Shang, Qipeng Yuan, Jinbo Yue. Mapping the frontiers: a bibliometric perspective on t cell-based immunotherapy in pancreatic cancer since the twenty-first century. Journal of Cancer Research and Clinical Oncology 2025; 151(12) doi: 10.1007/s00432-025-06356-x
|
| 4 |
Patrick Schmidt, Johannes Lindemeyer, Pranali Raut, Markus Schütz, Sven Saniternik, Jannika Jönsson, Heike Endepols, Thomas Fischer, Alexander Quaas, Hans Anton Schlößer, Martin Thelen, Holger Grüll. Multiparametric Characterization of the DSL-6A/C1 Pancreatic Cancer Model in Rats. Cancers 2024; 16(8): 1535 doi: 10.3390/cancers16081535
|
| 5 |
Nabeel Merali, Maria-Danae Jessel, Edward H. Arbe-Barnes, Wing Yu Ruby Lee, Martha Gismondi, Tarak Chouari, James W. O'Brien, Bhavik Patel, Daniel Osei-Bordom, Timothy A. Rockall, Shivan Sivakumar, Nicola Annels, Adam E. Frampton. Impact of tertiary lymphoid structures on prognosis and therapeutic response in pancreatic ductal adenocarcinoma. HPB 2024; 26(7): 873 doi: 10.1016/j.hpb.2024.04.009
|
| 6 |
Zhongfei Zhu, Gang Nie, Xiaobo Peng, Xianbao Zhan, Dan Ding. KAT8 catalyzes the acetylation of SEPP1 at lysine 247/249 and modulates the activity of CD8+ T cells via LRP8 to promote anti-tumor immunity in pancreatic cancer. Cell & Bioscience 2025; 15(1) doi: 10.1186/s13578-025-01356-3
|
| 7 |
Mengfei Li, Hongyu Chen, Dingchuan Peng, Xuehan Lu, Jianping Kong, Shujun Luo, Shiqi Li, Chunlu Tan, Ying Wang. FU-coating pH-sensitive liposomes for improving the release of gemcitabine by endosome escape in pancreatic cancer cells. Journal of Drug Delivery Science and Technology 2023; 80: 104135 doi: 10.1016/j.jddst.2022.104135
|
| 8 |
Shungang Zhang, Elaina R. Daniels, Jake McGue, Ranga Sudharshan, Hongsun C. Kim, Dafydd G. Thomas, Santhoshi Krishnan, Timothy L. Frankel, Erika Hissong, Arvind Rao, Naziheh Assarzadegan, Jiaqi Shi. Elevated T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT) Expression and Immune Cell Dysfunction Characterize Complex Proteins Associated With SET1 (COMPASS)–Like Complex Gene–Mutated Pancreatic Ductal Adenocarcinoma (PDAC). Modern Pathology 2026; 39(4): 100972 doi: 10.1016/j.modpat.2026.100972
|
| 9 |
Xiaolong Liu, Qingzhu Ding, Han Zhang, Xiang Zhang, Qiangda Chen, Shangeng Weng. The CD39-CD73-adenosine axis: Master regulator of immune evasion and therapeutic target in pancreatic ductal adenocarcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2025; 1880(5): 189443 doi: 10.1016/j.bbcan.2025.189443
|
| 10 |
Sunil Kumar Singh, Sandeep Kumar, Saket Jha, Navin Viswakarma, Harsh Vyas, Piush Srivastava, Rakesh Sathish Nair, Sowdhamini Mahendiran, Niraj Nag, Periannan Sethupathi, Basabi Rana, Jose Trevino, Ajay Rana. MAP4K4 regulates the immune landscape of pancreatic tumor microenvironment and provides an opportunity for immunotherapy. Cancer Letters 2026; 644: 218336 doi: 10.1016/j.canlet.2026.218336
|
| 11 |
Yuki Mochida, Kenoki Ohuchida, Bo Zhang, Yutaka Yamada, Chikanori Tsutsumi, Akihiro Kubo, Koki Oyama, Tomohiko Shinkawa, Chika Iwamoto, Nobuhiro Torata, Toshiya Abe, Noboru Ideno, Naoki Ikenaga, Kohei Nakata, Yoshinao Oda, Masafumi Nakamura. Identification of cold tumor induction–related markers in pancreatic cancer and the clinical implication of PCDH7. Journal of Cancer Research and Clinical Oncology 2025; 151(2) doi: 10.1007/s00432-025-06095-z
|
| 12 |
Behnia Akbari, Tahereh Soltantoyeh, Zahra Shahosseini, Farhad Jadidi-Niaragh, Jamshid Hadjati, Christine E. Brown, Hamid Reza Mirzaei. PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1209572
|
| 13 |
Casper W.F. van Eijck, Jie Ju, Freek R. van ’t Land, Maaike Verheij, Yunlei Li, Andrew Stubbs, Michael Doukas, Karishma Lila, Lara R. Heij, Georg Wiltberger, Lola Alonso, Núria Malats, Bas Groot Koerkamp, Eveline E. Vietsch, Casper H.J. van Eijck. The tumor immune microenvironment in resected treatment-naive pancreatic cancer patients with long-term survival. Pancreatology 2024; 24(7): 1057 doi: 10.1016/j.pan.2024.08.014
|
| 14 |
Ann Mary Joseph, Ahmad Al Aiyan, Basel Al-Ramadi, Shiv K. Singh, Uday Kishore. Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1323198
|
| 15 |
Dijana Perovic, Marija Dusanovic Pjevic, Vladimir Perovic, Milka Grk, Milica Rasic, Maja Milickovic, Tanja Mijovic, Petar Rasic. B7 homolog 3 in pancreatic cancer. World Journal of Gastroenterology 2024; 30(31): 3654-3667 doi: 10.3748/wjg.v30.i31.3654
Abstract(660) |
Core Tip(679) |
Full Article(HTML)(4254)
|
Full Article with Cover (PDF)-2312K(179)
|
Audio-879K(20)
|
Peer-Review Report-207K(116)
|
Answering Reviewers-205K(123)
|
Supplementary Material-418K(131)
|
Full Article (PDF)-1719K(254)
|
Full Article (XML)-258K(126)
|
Times Cited (3)
|
Total Visits (10101)
|
Open
|
| 16 |
Shamik Mascharak, Jason L. Guo, Deshka S. Foster, Anum Khan, Michael F. Davitt, Alan T. Nguyen, Austin R. Burcham, Malini S. Chinta, Nicholas J. Guardino, Michelle Griffin, David M. Lopez, Elisabeth Miller, Michael Januszyk, Shyam S. Raghavan, Teri A. Longacre, Daniel J. Delitto, Jeffrey A. Norton, Michael T. Longaker. Desmoplastic stromal signatures predict patient outcomes in pancreatic ductal adenocarcinoma. Cell Reports Medicine 2023; 4(11): 101248 doi: 10.1016/j.xcrm.2023.101248
|
| 17 |
Hanieh Noormohamadi, Hamed Soleimani Samarkhazan, Maryam kargar, Faezeh Maroufi, Nazli Servatian, Fatemeh Davami. CRISPR/Cas technologies in pancreatic cancer research and therapeutics: recent advances and future outlook. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-03383-5
|
| 18 |
Ying Ling, Chunhui Xi, Jun Wang, Luting Wang, Xin Cao, Juan Liu. HRASLS2 promotes the growth and glycolysis of pancreatic cancer by enhancing the stability of ASPH. Naunyn-Schmiedeberg's Archives of Pharmacology 2026; 399(2): 2307 doi: 10.1007/s00210-025-04522-z
|
| 19 |
Songyu Guo, Zhenxia Wang. Unveiling the immunosuppressive landscape of pancreatic ductal adenocarcinoma: implications for innovative immunotherapy strategies. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1349308
|
| 20 |
Sreejith T, Kaladhar Kamalasanan, Sneha S, Pavithran Keechilat, Hani Harb. Advancing Cancer Treatment Through Nanotechnology Driven Immunotherapy for Pancreatic Cancer. ACS Applied Nano Materials 2023; 6(20): 18670 doi: 10.1021/acsanm.3c03454
|
| 21 |
Abhinav Shenoy, Amar Yousif, Muhammad Delwar Hussain. Recent Advances and Challenges in the Treatment of Advanced Pancreatic Cancer: An Update on Completed and Ongoing Clinical Trials. Cancers 2025; 17(8): 1319 doi: 10.3390/cancers17081319
|
| 22 |
|
| 23 |
Melissa R. Lyman, Jacob T. Mitchell, Sidharth Raghavan, Luciane T. Kagohara, Amanda L. Huff, Saurav D. Haldar, Sarah M. Shin, Samantha Guinn, Benjamin Barrett, Gabriella Longway, Alexei Hernandez, Erin M. Coyne, Xuan Yuan, Lalitya Andaloori, Jiaying Lai, Yun Zhou Liu, Rachel Karchin, Anuj Gupta, Ashley L. Kiemen, André Forjaz, Denis Wirtz, Pei-Hsun Wu, Atul Deshpande, Jae W. Lee, Todd D. Armstrong, Nilofer S. Azad, Jacquelyn W. Zimmerman, Laura D. Wood, Robert A. Anders, Elizabeth D. Thompson, Elizabeth M. Jaffee, Elana J. Fertig, Won Jin Ho, Neeha Zaidi. Spatial proteomics and transcriptomics reveal early immune cell organization in pancreatic intraepithelial neoplasia. JCI Insight 2025; 10(15) doi: 10.1172/jci.insight.191595
|
| 24 |
Ashwin Jainarayanan, Nithishwer Mouroug-Anand, Edward H. Arbe-Barnes, Adam J. Bush, Rachael Bashford-Rogers, Adam Frampton, Lara Heij, Mark Middleton, Michael L. Dustin, Enas Abu-Shah, Shivan Sivakumar. Pseudotime dynamics of T cells in pancreatic ductal adenocarcinoma inform distinct functional states within the regulatory and cytotoxic T cells. iScience 2023; 26(4): 106324 doi: 10.1016/j.isci.2023.106324
|
| 25 |
Christine S. Hughes, Oleg Blyuss, Hemant M. Kocher. Plasma vascular endothelial growth factor levels are a potential therapy-response biomarker for pancreatic cancer. Frontiers in Oncology 2026; 15 doi: 10.3389/fonc.2025.1672385
|
| 26 |
Hang Yu, Wenting Zhu, Caiyan Lin, Menglei Jia, Xiaoxiao Tan, Zhongwen Yuan, Senglin Feng, Pengke Yan. Stromal and tumor immune microenvironment reprogramming through multifunctional cisplatin-based liposomes boosts the efficacy of anti-PD-1 immunotherapy in pancreatic cancer. Biomaterials Science 2024; 12(1): 116 doi: 10.1039/D3BM01118F
|
| 27 |
Francesca R. Delvecchio, Rachel E.A. Fincham, Sarah Spear, Andrew Clear, Marina Roy-Luzarraga, Frances R. Balkwill, John G. Gribben, Michele Bombardieri, Kairbaan Hodivala-Dilke, Melania Capasso, Hemant M. Kocher. Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice. Cellular and Molecular Gastroenterology and Hepatology 2021; 12(5): 1543 doi: 10.1016/j.jcmgh.2021.06.023
|
| 28 |
Jennifer M. Finan, Yifei Guo, Shaun M. Goodyear, Jonathan R. Brody. Challenges and Opportunities in Targeting the Complex Pancreatic Tumor Microenvironment. JCO Oncology Advances 2024; (1) doi: 10.1200/OA-24-00050
|
| 29 |
Leonardo Mercanti, Maria Sindaco, Mariangela Mazzone, Maria Carmela Di Marcantonio, Mariagrazia Piscione, Raffaella Muraro, Gabriella Mincione. PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies. Cancers 2023; 15(11): 2923 doi: 10.3390/cancers15112923
|
| 30 |
Daniele P. Ferrari, Özmen Çobanoglu, Sana Sayedipour, Omar Luna, Sonia A. M. Ferkel, David Agorku, Yomkippur Perez, Luis J. Cruz, Fernando Albericio, François Trottein, Frauke Alves, Marietta Andrea Markus, Fernanda Ramos-Gomes. Anti-Tumor Efficacy of a Mesothelin-Based Nanovaccine in a KPC Orthotopic Mouse Model of Pancreatic Cancer. Vaccines 2025; 13(3): 314 doi: 10.3390/vaccines13030314
|
| 31 |
Immacolata Maietta, África González-Fernández, Rosana Simón-Vázquez. Harnessing epigenetic inhibitors: A promising approach for overcoming challenges in pancreatic ductal adenocarcinoma treatment. Advanced Drug Delivery Reviews 2025; 224: 115638 doi: 10.1016/j.addr.2025.115638
|
| 32 |
Othman Saleh, Hani Shihadeh, Ahmad Yousef, Hana Erekat, Fatima Abdallh, Ahmad Al-leimon, Rawan Elsalhy, Abdalrahman Altiti, Majd Dajani, Majd M. AlBarakat. The Effect of Intratumor Heterogeneity in Pancreatic Ductal Adenocarcinoma Progression and Treatment. Pancreas 2024; 53(5): e450 doi: 10.1097/MPA.0000000000002342
|
| 33 |
Shreyas Gaikwad, Sanjay K. Srivastava. Reprogramming tumor immune microenvironment by milbemycin oxime results in pancreatic tumor growth suppression and enhanced anti-PD-1 efficacy. Molecular Therapy 2024; 32(9): 3145 doi: 10.1016/j.ymthe.2024.07.029
|
| 34 |
Guixing Jiang, Xinyang Zhou, Shehuang Chen, Faming Zhong, Gaoshi Huang, Bicheng Wu, Qiaoyan Mou, Gang Jiang, Tianyu Lin. SATB2 plays a critical role in pancreatic cancer cell proliferation, migration and T cell cytotoxicity. Cancer Genetics 2025; : 53 doi: 10.1016/j.cancergen.2025.06.006
|
| 35 |
William J MacDonald. Inhibition of ITGB6 stimulates potent anti-tumor responses in immunocompetent mouse models of head and neck squamous cell carcinoma and pancreatic adenocarcinoma. American Journal of Cancer Research 2025; 15(12): 5317 doi: 10.62347/MEAD1055
|
| 36 |
Julia Persky, Sylvia M. Cruz, Morgan A. Darrow, Sean J. Judge, Yueju Li, Richard J. Bold, Anthony N. Karnezis, Karen E. Matsukuma, Lihong Qi, Robert J. Canter. Characterization of natural killer and cytotoxic T‐cell immune infiltrates in pancreatic ductal adenocarcinoma. Journal of Surgical Oncology 2024; 129(5): 885 doi: 10.1002/jso.27581
|
| 37 |
Ashley P. Tsang, Santhoshi N. Krishnan, Reva Kulkarni, Sagnik Bhadury, Marina Pasca di Magliano, Timothy L. Frankel, Arvind Rao. Encoding functional edges in graphs to model spatially varying relationships in the tumor microenvironment. npj Artificial Intelligence 2026; 2(1) doi: 10.1038/s44387-026-00075-5
|
| 38 |
Sawsan Sudqi Said, Wisam Nabeel Ibrahim. Cancer Resistance to Immunotherapy: Comprehensive Insights with Future Perspectives. Pharmaceutics 2023; 15(4): 1143 doi: 10.3390/pharmaceutics15041143
|
| 39 |
Jens von den Driesch, Jana Flöttmann, Friedrich Prall, Christina S. Mullins, Michael Linnebacher, Florian Bürtin. HROP68: A rare case of medullary pancreatic cancer—characterization and chemosensitivity of the first patient-derived cell line. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1082927
|
| 40 |
Anja Geisler, Babette Dieringer, Leslie Elsner, Maxim Girod, Sophie Van Linthout, Jens Kurreck, Henry Fechner. Sensitivity of Pancreatic Cancer Cell Lines to Clinically Approved FAK Inhibitors: Enhanced Cytotoxicity Through Combination with Oncolytic Coxsackievirus B3. International Journal of Molecular Sciences 2025; 26(14): 6877 doi: 10.3390/ijms26146877
|
| 41 |
Sridevi Mardham, Soumya Dakshinamurthy. Immune Therapy for Pancreatic and Colon Cancers. 2025; : 199 doi: 10.1016/B978-0-443-24742-2.00005-8
|
| 42 |
Nnenna Elebo, Ebtesam A. Abdel-Shafy, Jones A. O. Omoshoro-Jones, Zanele Nsingwane, Ahmed A. A. Hussein, Martin Smith, Geoffrey Candy, Stefano Cacciatore, Pascaline Fru, Ekene Emmanuel Nweke. Comparative immune profiling of pancreatic ductal adenocarcinoma progression among South African patients. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12595-x
|
| 43 |
Angha Naik, Andrew Leask. Tumor-associated fibrosis impairs the response to immunotherapy. Matrix Biology 2023; 119: 125 doi: 10.1016/j.matbio.2023.04.002
|
| 44 |
Pooria Salehi-Sangani, Amir Hosein Maharati, Bahareh Payami, Mohsen Aliakbarian, Mohammad Reza Abbaszadegan. HypoxamiRs in pancreatic cancer: master regulators of the hypoxic tumor microenvironment. Cell Biology and Toxicology 2025; 41(1) doi: 10.1007/s10565-025-10092-w
|
| 45 |
Matteo Ponzo, Anais Debesset, Mélissande Cossutta, Mounira Chalabi-Dchar, Claire Houppe, Caroline Pilon, Alba Nicolas-Boluda, Sylvain Meunier, Fabio Raineri, Allan Thiolat, Rémy Nicolle, Federica Maione, Serena Brundu, Carina Florina Cojocaru, Philippe Bouvet, Corinne Bousquet, Florence Gazeau, Christophe Tournigand, José Courty, Enrico Giraudo, José L. Cohen, Ilaria Cascone. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022; 14(17): 4265 doi: 10.3390/cancers14174265
|
| 46 |
Khandoker Usran Ferdous, Mulu Z. Tesfay, Aleksandra Cios, Randal S. Shelton, Conner Hartupee, Alicja Urbaniak, Jean Christopher Chamcheu, Michail N. Mavros, Emmanouil Giorgakis, Bahaa Mustafa, Camila C. Simoes, Isabelle R. Miousse, Alexei G. Basnakian, Omeed Moaven, Steven R. Post, Martin J. Cannon, Thomas Kelly, Bolni Marius Nagalo. Enhancing Neoadjuvant Virotherapy’s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer. Biomedicines 2024; 12(7): 1596 doi: 10.3390/biomedicines12071596
|
| 47 |
Junzhu Dai, Yuxiang Han, Tianyi Fang, Hongxue Shao, Lei Teng, Huichao Zou. Clinical Significance of Mean Platelet Volume Combined with Neutrophil–Lymphocyte Ratio in Predicting the Therapeutic Effect of Splanchnic Neurolysis. Journal of Inflammation Research 2023; : 5027 doi: 10.2147/JIR.S428641
|
| 48 |
Mohammed Salih AL-Janaby, Salah H. Mannoush, Saif S. Al-Janabi, Ahmed AbdulJabbar Suleiman, Ali Hazim Abdulkareem, Anmar Kamil Alalwani, Mustafa M. Fahad. Bioinformatics-based Investigation to Unveiling The miRNA-Immunity Axis in The Tumor Microenvironment of Pancreatic Cancer. F1000Research 2025; 14: 1404 doi: 10.12688/f1000research.172407.1
|
| 49 |
Uri Amit, Ugur Uslu, Ioannis I. Verginadis, Michele M. Kim, Seyyedeh Azar Oliaei Motlagh, Eric S. Diffenderfer, Charles-Antoine Assenmacher, Sandra Bicher, Sebastian J. Atoche, Edgar Ben-Josef, Regina M. Young, Carl H. June, Constantinos Koumenis. Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic cancer. Proceedings of the National Academy of Sciences 2024; 121(31) doi: 10.1073/pnas.2403002121
|
| 50 |
Laura Drndakova, Lucia Juhasikova, Ivana Hlavenova, Verona Buocikova, Sara Durdiakova, Michal Mego, Milan Buc, Bozena Smolkova. Epigenetic modulation to overcome immune suppression in pancreatic cancer. Clinical Epigenetics 2026; doi: 10.1186/s13148-026-02081-5
|
| 51 |
Milica Dimitrijevic Stojanovic, Bojan Stojanovic, Ivan Radosavljevic, Vojin Kovacevic, Ivan Jovanovic, Bojana S. Stojanovic, Nikola Prodanovic, Vesna Stankovic, Miodrag Jocic, Marina Jovanovic. Galectin-3’s Complex Interactions in Pancreatic Ductal Adenocarcinoma: From Cellular Signaling to Therapeutic Potential. Biomolecules 2023; 13(10): 1500 doi: 10.3390/biom13101500
|
| 52 |
Luis Guilherme de Oliveira Silva, Fabian Fellipe Bueno Lemos, Marcel Silva Luz, Samuel Luca Rocha Pinheiro, Mariana dos Santos Calmon, Gabriel Lima Correa Santos, Gabriel Reis Rocha, Fabrício Freire de Melo. New avenues for the treatment of immunotherapy-resistant pancreatic cancer. World Journal of Gastrointestinal Oncology 2024; 16(4): 1134-1153 doi: 10.4251/wjgo.v16.i4.1134
|
| 53 |
Rawaa AlChalabi, Raghda Makia, Semaa A. Shaban, Ahmed AbdulJabbar Suleiman. Characterizing immune biomarkers and effector CD8+ T-cell exhaustion in pancreatic adenocarcinoma via single-cell RNA sequencing profiling. Exploration of Immunology 2025; doi: 10.37349/ei.2025.1003179
|
| 54 |
Shichen Zhang, Na Ta, Shihao Zhang, Senhao Li, Xinyu Zhu, Lingyun Kong, Xueqing Gong, Meng Guo, Yanfang Liu. Unraveling pancreatic ductal adenocarcinoma immune prognostic signature through a naive B cell gene set. Cancer Letters 2024; 594: 216981 doi: 10.1016/j.canlet.2024.216981
|
| 55 |
Laura Miró, Júlia López, Pedro E. Guerrero, Neus Martínez-Bosch, Noemí Manero-Rupérez, Mireia Moreno, M. Rosa Ortiz, Esther Llop, Pilar Navarro, Rosa Peracaula. Sialyltransferase Inhibitor Ac53FaxNeu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in Mice. Cancers 2022; 14(24): 6133 doi: 10.3390/cancers14246133
|
| 56 |
Chien-Yu Chou, Zhi-Qin Li, Hsiao-Chen Huang, Chung-Heng Hung, Shun-Long Weng, Shey-Cherng Tzou. Development of an Albumin-Masked mutPD-1Ig as a Tumor Lesion-Selective Immune Checkpoint Inhibitor. ACS Omega 2023; 8(43): 40911 doi: 10.1021/acsomega.3c06216
|
| 57 |
Roshini Pradeep, Nooredeen Jamal Isbeih, Freya F. Abraham, Ehsan Noori, Zachary P. Yeung, Madappa N. Kundranda. KRAS Inhibition in Pancreatic Ductal Adenocarcinoma. Journal of Clinical Medicine 2026; 15(2): 873 doi: 10.3390/jcm15020873
|
| 58 |
Muhammad Usman Saleem, Hammad Ali Sajid, Muhammad Waqar Arshad, Alejandro Omar Rivera Torres, Muhammad Imran Shabbir, Sunil Kumar Rai. Novel Insights into T-Cell Exhaustion and Cancer Biomarkers in PDAC Using ScRNA-Seq. Biology 2025; 14(8): 1015 doi: 10.3390/biology14081015
|
| 59 |
Taymin du Toit-Thompson, Lionel Leck, Josef Gillson, Nick Pavlakis, Anthony J. Gill, Jaswinder S. Samra, Anubhav Mittal, Sumit Sahni. Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies. Advanced Drug Delivery Reviews 2025; 224: 115647 doi: 10.1016/j.addr.2025.115647
|
| 60 |
Joanna Napp, Paulina Siebel, Hans Rausch, Kenny Kuchta, Thomas Efferth, Frauke Alves, Volker Ellenrieder, Silke Cameron. Prolonged survival by combination treatment with a standardized herbal extract from Japanese Kampo-medicine (Juzentaihoto) and gemcitabine in an orthotopic transplantation pancreatic cancer model. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1454291
|
| 61 |
Jason L. Guo, David M. Lopez, Shamik Mascharak, Deshka S. Foster, Anum Khan, Michael F. Davitt, Alan T. Nguyen, Austin R. Burcham, Malini S. Chinta, Nicholas J. Guardino, Michelle Griffin, Elisabeth Miller, Michael Januszyk, Shyam S. Raghavan, Teri A. Longacre, Daniel J. Delitto, Jeffrey A. Norton, Michael T. Longaker. Hematoxylin and Eosin Architecture Uncovers Clinically Divergent Niches in Pancreatic Cancer. Tissue Engineering Part A 2024; 30(19-20): 605 doi: 10.1089/ten.tea.2024.0039
|
| 62 |
Lina Gross, Ivanina Mutisheva, Hanne Hillen, Steve Robatel, Martin Wartenberg, Feiyang Ma, Lukas Bäriswyl, Delphine J. Lee, Robert L. Modlin, Kaspar Z’graggen, Mirjam Schenk. TREM-1 as a novel immunotherapeutic target to treat pancreatic ductal adenocarcinoma. Molecular Therapy Oncology 2025; 33(3): 201034 doi: 10.1016/j.omton.2025.201034
|
| 63 |
Kartik Mittal, Neha Rathi, Devika Tripathi, Paruvathanahalli Siddalingam Rajinikanth, Prashant Pandey. Targeting the Tumour Microenvironment in Pancreatic Cancer: From Stromal Reprogramming to Emerging Therapeutics. Future Pharmacology 2026; 6(1): 12 doi: 10.3390/futurepharmacol6010012
|
| 64 |
Ting Yang, Qiao-Qi Li, Yong-Mei Liu, Biao Yang. T cells in pancreatic cancer stroma: Tryptophan metabolism plays an important role in immunoregulation. World Journal of Gastroenterology 2023; 29(17): 2701-2703 doi: 10.3748/wjg.v29.i17.2701
|
| 65 |
Elias Quijano, Diana Martinez-Saucedo, Zaira Ianniello, Natasha Pinto-Medici, Madison Rackear, Haoting Chen, Luiz Lola-Pereira, Yanfeng Liu, Denise Hegan, Xinning Shan, Robert Tseng, Deanne Yugawa, Sumedha Chowdhury, Minsoo Khang, Jay P. Singh, Rashed Abdullah, Perisa Azhir, Soki Kashima, Wendy S. Woods, Nicholas Gosstola, Bruce C. Turner, Stephen Squinto, Dale L. Ludwig, Ranjit S. Bindra, Marie E. Robert, David A. Braun, Pablo Perez Pinera, W. Mark Saltzman, Luisa F. Escobar-Hoyos, Peter M. Glazer. Systemic administration of an RNA binding and cell-penetrating antibody targets therapeutic RNA to multiple mouse models of cancer. Science Translational Medicine 2025; 17(807) doi: 10.1126/scitranslmed.adk1868
|
| 66 |
Matthew Bloom, Ali Raza Shaikh, Zhengyang Sun, Babar Bashir, Adam E. Snook. Cancer Vaccination and Immune-Based Approaches in Pancreatic Cancer. Cancers 2025; 17(14): 2356 doi: 10.3390/cancers17142356
|
| 67 |
Fotini Poyia, Christiana M. Neophytou, Maria-Ioanna Christodoulou, Panagiotis Papageorgis. The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future Perspectives. International Journal of Molecular Sciences 2024; 25(17): 9555 doi: 10.3390/ijms25179555
|
| 68 |
Nan Sheng, Koji Shindo, Kenoki Ohuchida, Tomohiko Shinkawa, Bo Zhang, Haimin Feng, Takeo Yamamoto, Taiki Moriyama, Naoki Ikenaga, Kohei Nakata, Yoshinao Oda, Masafumi Nakamura. TAK1 Promotes an Immunosuppressive Tumor Microenvironment through Cancer-Associated Fibroblast Phenotypic Conversion in Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research 2024; 30(22): 5138 doi: 10.1158/1078-0432.CCR-24-1004
|
| 69 |
Lyanne Delgado-Coka, Michael Horowitz, Mariana Torrente-Goncalves, Lucia Roa-Peña, Cindy V. Leiton, Mahmudul Hasan, Sruthi Babu, Danielle Fassler, Jaymie Oentoro, Ji-Dong K Bai, Emanuel F. Petricoin, Lynn M. Matrisian, Edik Matthew Blais, Natalia Marchenko, Felicia D. Allard, Wei Jiang, Brent Larson, Andrew Hendifar, Chao Chen, Shahira Abousamra, Dimitris Samaras, Tahsin Kurc, Joel Saltz, Luisa F. Escobar-Hoyos, Kenneth R. Shroyer. Keratin 17 modulates the immune topography of pancreatic cancer. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05252-1
|
| 70 |
Pancreatic Cancer: Basic Mechanisms and Therapies. Advances in Cancer Research 2023; 159: 145 doi: 10.1016/bs.acr.2023.02.004
|
| 71 |
Dae Ui Lee, Beom Seok Han, Kyung Hee Jung, Soon-Sun Hong. Tumor Stroma as a Therapeutic Target for Pancreatic Ductal Adenocarcinoma. Biomolecules & Therapeutics 2024; 32(3): 281 doi: 10.4062/biomolther.2024.029
|